The Federal Joint Committee has recognized the relevance of cold plasma therapy and confirmed this by confirmed this by initiating a trial study. The classification of the CPT®patch in the in the SHI benefits catalog has not yet been conclusively clarified. It is conceivable that the CPT®patch could be classified as a dressing and and therefore can be reimbursed without further ado according to the known principles of the is dispensable. However, it is also conceivable that it could be classified as another wound care product or as part of a new of a new method and can therefore only be dispensed at the present time with only if approved by the health insurance company. In this situation, it is advisable in the interest of protecting against retaxation to obtain authorization from the the health insurance company before dispensing the CPT®patch, that it recognizes its obligation to provide benefits. For the confirmation of the obligation to pay benefits to be declared to the insured person the treating physician should state the individual severity of the illness and, above all the unsuccessful exhaustion of all more cost-effective alternatives and the available evidence. evidence available.